Auspex Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Auspex Pharmaceuticals Ownership

Who owns Auspex Pharmaceuticals?

Auspex Pharmaceuticals is owned by Teva Pharmaceutical Industries. It was acquired on May 5, 2015.

Auspex Pharmaceuticals Business Overview

Where is Auspex Pharmaceuticals headquartered?

Auspex Pharmaceuticals is headquartered in San Diego, California.

How many employees does Auspex Pharmaceuticals have?

Auspex Pharmaceuticals has 35 employees.

What sector is Auspex Pharmaceuticals in?

Auspex Pharmaceuticals is a life science company.

When was Auspex Pharmaceuticals founded?

Auspex Pharmaceuticals was founded in 2001.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Auspex Pharmaceuticals, Inc.

3366 North Torrey Pines Court,
San Diego, California 92037
United States,
(858) 558-2400
www.auspexpharma.com

Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. It is a developer of innovative medicines for hyperkinetic movement disorders and other rare diseases.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.